Silk Road Medical Inc (OQ:SILK)

Business Focus: Medical Equipment, Supplies & Distribution

Apr 09, 2024 04:30 pm ET
Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the first quarter 2024 after market close on Tuesday, April 30th, 2024....
Apr 02, 2024 04:30 pm ET
Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the launch of its ENROUTE® Transcarotid Neuroprotection System PLUS (“NPS PLUS”), a key component of the TCAR®...
Mar 05, 2024 09:00 am ET
Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that it has launched its Tapered ENROUTE Transcarotid Stent System to hospitals in the United States. This launch...
Feb 28, 2024 04:05 pm ET
Silk Road Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Financial Outlook
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months and full year ended December 31, 2023. “With the right team in place,...
Feb 07, 2024 04:30 pm ET
Silk Road Medical to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the fourth quarter and full year 2023 after market close on Wednesday,...
Dec 20, 2023 04:30 pm ET
Silk Road Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming 42nd Annual J.P. Morgan Healthcare Conference. Management is...
Nov 21, 2023 05:56 pm ET
Silk Road Medical (SILK) Stock Tanks After Revenues Lowered and CEO Leaves – Hagens Berman
Hagens Berman encourages Silk Road Medical, Inc. (NASDAQ: SILK) investors who suffered substantial losses to submit your losses now. Hagens Berman is investigating potential violations of the securities laws. Visit:...
Nov 13, 2023 06:53 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Silk Road Medical, Inc. - SILK
Pomerantz LLP is investigating claims on behalf of investors of Silk Road Medical, Inc. (“Silk Road” or the “Company”) (NASDAQ: SILK).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980....
Nov 13, 2023 04:07 pm ET
Silk Road Medical (SILK) Investors with Substantial Losses Encouraged to Contact Hagens Berman, National Trial Attorneys: Firm Investigating Possible Securities Law Violations
Hagens Berman encourages Silk Road Medical, Inc. (NASDAQ: SILK) investors who suffered substantial losses to submit your losses now. Hagens Berman is investigating potential violations of the securities laws. Visit:...
Nov 08, 2023 04:05 pm ET
Silk Road Medical Reports Third Quarter 2023 Financial Results
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended September 30, 2023. “As announced on November 2, we are thrilled to...
Nov 05, 2023 03:22 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Silk Road Medical, Inc. - SILK
Pomerantz LLP is investigating claims on behalf of investors of Silk Road Medical, Inc. (“Silk Road” or the “Company”) (NASDAQ: SILK). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980....
Nov 03, 2023 06:31 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Silk Road Medical, Inc. - SILK
NEW YORK, Nov. 3, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Silk Road Medical, Inc. ("Silk Road" or the "Company") (NASDAQ: SILK). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Nov 02, 2023 08:00 am ET
Silk Road Medical Names Chas McKhann Chief Executive Officer
Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road” or the “Company”), a company focused on reducing the risk of stroke and its devastating impact, today announced that Chas McKhann has been appointed Chief Executive Officer (CEO), effective...
Oct 31, 2023 02:02 pm ET
Hagens Berman- Silk Road Medical (SILK) Stock Tanks After Revenues Lowered and CEO Leaves
Hagens Berman encourages Silk Road Medical, Inc. (NASDAQ: SILK) investors who suffered substantial losses to submit your losses now. Hagens Berman is investigating potential violations of the securities laws. Visit:...
Oct 27, 2023 02:47 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Silk Road Medical, Inc. - SILK
Pomerantz LLP is investigating claims on behalf of investors of Silk Road Medical, Inc. (“Silk Road” or the “Company”) (NASDAQ: SILK). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980....
Oct 26, 2023 04:30 pm ET
Silk Road Medical to Report Third Quarter 2023 Financial Results on November 8, 2023
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the third quarter 2023 after market close on Wednesday, November 8th, 2023....
Oct 25, 2023 05:38 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Silk Road Medical, Inc. - SILK
NEW YORK, Oct. 25, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Silk Road Medical, Inc. ("Silk Road" or the "Company") (NASDAQ: SILK).  Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Oct 25, 2023 10:25 am ET
Silk Road Medical (SILK) Stock Tanks After Revenues Lowered and CEO Leaves – Hagens Berman Firm Encourages Investors with Substantial Losses to Contact its Attorneys
Hagens Berman encourages Silk Road Medical, Inc. (NASDAQ: SILK) investors who suffered substantial losses to submit your losses now. Hagens Berman is investigating potential violations of the securities laws. Visit:...
Oct 19, 2023 03:17 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Silk Road Medical, Inc. - SILK
Pomerantz LLP is investigating claims on behalf of investors of Silk Road Medical, Inc. (“Silk Road” or the “Company”) (NASDAQ: SILK).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980....
Oct 17, 2023 03:10 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Silk Road Medical, Inc. - SILK
NEW YORK, Oct. 17, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Silk Road Medical, Inc. ("Silk Road" or the "Company") (NASDAQ: SILK). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Oct 16, 2023 11:29 am ET
Silk Road Medical (SILK) Investors with Substantial Losses Encouraged to Contact Hagens Berman, National Trial Attorneys: Firm Investigating Possible Securities Law Violations
Hagens Berman encourages Silk Road Medical, Inc. (NASDAQ: SILK) investors who suffered substantial losses to submit your losses now. Hagens Berman is investigating potential violations of the securities laws. Visit:...
Oct 12, 2023 09:31 am ET
Thinking about buying stock in Sellas Life Sciences Group, Silk Road Medical, Hyliion Holdings, 89bio, or OpGen?
NEW YORK, Oct. 12, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SLS, SILK, HYLN, ETNB, and OPGN.
Oct 11, 2023 06:16 pm ET
Silk Road Medical Stock (SILK) Nosedives on CEO Departure and Revenue Shortfall
Hagens Berman encourages Silk Road Medical, Inc. (NASDAQ: SILK) investors who suffered substantial losses to submit your losses now. Hagens Berman is investigating potential violations of the securities laws. Visit:...
Oct 11, 2023 01:43 pm ET
SILK SHAREHOLDER ALERT: Johnson Fistel Encourages Silk Road Medical Shareholders with Losses to Contact the Firm Regarding Investigation
Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether Silk Road Medical, Inc (NASDAQ: SILK), any of its executive officers or others violated securities laws by misrepresenting or failing to timely...
Oct 10, 2023 04:20 pm ET
Silk Road Medical Announces Preliminary Third Quarter 2023 Revenue and Provides Revised 2023 Outlook
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced preliminary revenue for the quarter ended September 30, 2023, and provided an update to full year 2023 revenue...
Oct 10, 2023 04:20 pm ET
Silk Road Medical Announces Retirement of CEO Erica Rogers
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that CEO Erica Rogers plans to retire from the Company following the completion of a succession process. The...
Sep 04, 2023 04:30 pm ET
Silk Road Medical to Present at the CL King 21st Annual Best Ideas Conference
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that management will present at the CL King 21st Annual Best Ideas Conference. Management is scheduled to present...
Aug 03, 2023 04:30 pm ET
Silk Road Medical to Present at the UBS MedTech, Tools and Genomics Summit
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will participate in the upcoming UBS MedTech, Tools and Genomics Summit. Management is scheduled to...
Aug 01, 2023 04:05 pm ET
Silk Road Medical Reports Second Quarter 2023 Financial Results
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended June 30, 2023. “Silk Road is the leading force in stroke prevention...
Jul 12, 2023 09:31 am ET
Thinking about buying stock in Ault Alliance, Healthcare Triangle, Liminal BioSciences, ShiftPixy, or Silk Road Medical?
NEW YORK, July 12, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AULT, HCTI, LMNL, PIXY, and SILK.
Jul 11, 2023 04:30 pm ET
Silk Road Medical to Report Second Quarter 2023 Financial Results on August 1, 2023
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the second quarter 2023 after market close on Tuesday, August 1st, 2023....
May 09, 2023 04:05 pm ET
Silk Road Medical Reports First Quarter 2023 Financial Results
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended March 31, 2023. “2023 is off to a strong start as we execute against...
May 05, 2023 09:00 am ET
Silk Road Medical Receives 2023 Great Place To Work Certification™
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that it has been Certified™ by Great Place To Work® for the 3rd year in a row. The prestigious award is based...
May 04, 2023 04:30 pm ET
Silk Road Medical Announces Investor Education Webcast with Key Opinion Leaders
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that the company will host an investor education webcast at 11:00 a.m. Eastern Time on Thursday, May 25, 2023. The...
Apr 26, 2023 04:30 pm ET
Silk Road Medical to Present at the BofA Securities 2023 Healthcare Conference
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will participate in the upcoming BofA Securities 2023 Healthcare Conference. Management is scheduled...
Apr 18, 2023 04:30 pm ET
Silk Road Medical to Report First Quarter 2023 Financial Results on May 9, 2023
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the first quarter 2023 after market close on Tuesday, May 9th, 2023. Company...
Feb 28, 2023 04:05 pm ET
Silk Road Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Outlook
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months and full year ended December 31, 2022. “Our fourth quarter closes the books...
Feb 07, 2023 09:00 am ET
Silk Road Medical to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the fourth quarter and full year 2022 after market close on Tuesday, February...
Dec 28, 2022 04:30 pm ET
Silk Road Medical to Present at the 41st Annual J.P. Morgan Healthcare Conference
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference. Silk Road...
Nov 08, 2022 04:05 pm ET
Silk Road Medical Reports Third Quarter 2022 Financial Results
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended September 30, 2022. “Our performance in the third quarter reflects...
Nov 03, 2022 04:30 pm ET
Silk Road Medical to Present at Upcoming Investor Conferences
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that management will present at the following investor conferences. Stifel 2022 Healthcare Conference...
Oct 25, 2022 04:30 pm ET
Silk Road Medical to Report Third Quarter 2022 Financial Results on November 8, 2022
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the third quarter 2022 after market close on Tuesday, November 8th, 2022....
Oct 18, 2022 07:46 pm ET
Silk Road Medical Announces Pricing of Public Offering
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the pricing of an underwritten public offering of 2,325,582 shares of its common stock at a public offering price...
Oct 17, 2022 08:03 pm ET
Silk Road Medical Announces Certain Preliminary Financial Data For Quarter Ended September 30, 2022
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced certain preliminary financial data for the quarter ended September 30, 2022. Summary Preliminary Financial Data...
Oct 17, 2022 04:25 pm ET
Silk Road Medical Announces Proposed Public Offering of Common Stock
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, announced today the commencement of a proposed underwritten public offering of $100 million of shares of its common stock.  In...
Sep 07, 2022 04:15 pm ET
Silk Road Medical Announces First Patient Enrolled in ROADSTER 3 Post Approval Study Evaluating TCAR® System in the Treatment of Standard Surgical Risk Patients
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced enrollment of the first patient in ROADSTER 3, the first prospective, multi-center, single-arm study to assess...
Aug 30, 2022 04:15 pm ET
Silk Road Medical to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in a fireside chat at the upcoming Morgan Stanley 20th Annual Global Healthcare...
Jul 26, 2022 04:05 pm ET
Silk Road Medical Reports Second Quarter 2022 Financial Results
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended June 30, 2022. “We achieved several important milestones in the second...
Jul 12, 2022 04:15 pm ET
Silk Road Medical to Report Second Quarter 2022 Financial Results on July 26, 2022
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the second quarter 2022 after market close on Tuesday, July 26, 2022. Company...
Jun 15, 2022 09:00 am ET
Silk Road Medical Announces Post Approval Study for the Treatment of Standard Surgical Risk Patients using TCAR
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced a prospective study to evaluate the TCAR® system in the treatment of standard surgical risk patients with carotid...
Jun 02, 2022 07:00 am ET
Silk Road Medical Announces Expanded Medicare Coverage for TCAR in Standard Surgical Risk Patients
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that the Centers for Medicare and Medicaid Services (CMS), through collaboration with the Society of Vascular...
May 31, 2022 09:00 am ET
Silk Road Medical Extends Cash Runway by Securing up to $250 Million in Debt Financing
Silk Road Medical, Inc. (Company) (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that it has entered into a new five-year loan arrangement with Oxford Finance LLC (Oxford) comprising up...
May 04, 2022 04:05 pm ET
Silk Road Medical Reports First Quarter 2022 Financial Results
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended March 31, 2022. “We demonstrated strong execution in the first...
May 02, 2022 08:30 am ET
Silk Road Medical Announces FDA Approval of Expanded Indications for the ENROUTE® Transcarotid Stent System
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that that the U.S. Food and Drug Administration (FDA) approved expanded indications for the ENROUTE stent to...
Apr 26, 2022 04:10 pm ET
Silk Road Medical to Present at the BofA Securities 2022 Healthcare Conference
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will participate in the upcoming BofA Securities 2022 Healthcare Conference. Management is scheduled...
Apr 13, 2022 04:15 pm ET
Silk Road Medical to Report First Quarter 2022 Financial Results on May 4, 2022
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the first quarter 2022 after market close on Wednesday, May 4, 2022. Company...
Feb 24, 2022 04:01 pm ET
Silk Road Medical Reports Fourth Quarter and Full Year 2021 Financial Results and Provides 2022 Financial Outlook
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months and full year ended December 31, 2021. “Our team and physicians had a...
Feb 03, 2022 04:30 pm ET
Silk Road Medical to Report Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the fourth quarter and full year 2021 after market close on Thursday, February...
Feb 02, 2022 04:30 pm ET
Silk Road Medical to Present at the 11th Annual SVB Leerink Global Healthcare Conference
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the 11th Annual SVB Leerink Global Healthcare Conference. Silk Road Medical’s...
Dec 30, 2021 04:30 pm ET
Silk Road Medical to Present at the 40th Annual J.P. Morgan Healthcare Conference
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming 40th Annual J.P. Morgan Healthcare Conference. Silk Road...
Nov 10, 2021 04:10 pm ET
Silk Road Medical to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in a fireside chat at the upcoming Piper Sandler 33rd Annual Virtual Healthcare...
Nov 09, 2021 04:05 pm ET
Silk Road Medical Reports Third Quarter 2021 Financial Results
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the quarter ended September 30, 2021. “I am incredibly proud of our team for continuing...
Nov 02, 2021 04:10 pm ET
Silk Road Medical to Present at the Stifel 2021 Virtual Healthcare Conference
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in a fireside chat at the upcoming Stifel 2021 Virtual Healthcare Conference....
Oct 21, 2021 04:10 pm ET
Silk Road Medical to Report Third Quarter 2021 Financial Results on November 9, 2021
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the third quarter 2021 after market close on Tuesday, November 9, 2021....
Sep 01, 2021 04:10 pm ET
Silk Road Medical to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in a fireside chat at the upcoming Morgan Stanley 19th Annual Global Healthcare...
Aug 18, 2021 04:15 pm ET
First Ever Analysis of TCAR in Standard Surgical Risk Patients Demonstrates Clinical Benefits in Large Comparative Dataset
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, is pleased to highlight positive results from an independent analysis of standard surgical risk patients undergoing carotid...
Jul 29, 2021 04:05 pm ET
Silk Road Medical Reports Second Quarter 2021 Financial Results
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the quarter ended June 30, 2021. “Our second quarter results reflect excellent commercial...
Jul 26, 2021 04:05 pm ET
Silk Road Medical Names Dr. Tanisha Carino to Board of Directors
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that it has appointed Dr. Tanisha Carino to its Board of Directors. Tanisha Carino, Ph.D., is a health policy...
Jul 16, 2021 04:05 pm ET
Silk Road Medical to Report Second Quarter 2021 Financial Results on July 29, 2021
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the second quarter 2021 after market close on Thursday, July 29, 2021. Company...
Jul 06, 2021 04:05 pm ET
First Ever Standard Surgical Risk Patient TCAR Data to be Presented at the Society for Vascular Surgery 2021 Vascular Annual Meeting
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that key data regarding standard risk patients undergoing treatment for atherosclerotic carotid disease, including...
Jun 22, 2021 04:05 pm ET
Silicon Valley-Based Silk Road Medical Announces Expansion to MSP Region
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, recently announced the opening of a new office in Plymouth, Minnesota, to accommodate growing demand for TransCarotid Artery...
May 04, 2021 04:05 pm ET
Silk Road Medical Reports First Quarter 2021 Financial Results
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the quarter ended March 31, 2021. “Our first quarter results were characterized by meaningful...
May 03, 2021 04:05 pm ET
Silk Road Medical to Present at BofA Securities 2021 Virtual Health Care Conference
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in a fireside chat at the upcoming BofA Securities 2021 Virtual Health Care...
Apr 20, 2021 04:05 pm ET
Silk Road Medical to Report First Quarter 2021 Financial Results on May 4, 2021
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the first quarter 2021 after market close on Tuesday, May 4, 2021. Company...
Apr 15, 2021 04:05 pm ET
Silk Road Medical Appoints William Hill as General Counsel
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the appointment of William Hill as General Counsel. The veteran corporate executive joins the company to oversee...
Mar 01, 2021 04:05 pm ET
Silk Road Medical Reports Fourth Quarter and Full Year 2020 Financial Results
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months and full year ended December 31, 2020. Silk Road Medical also announced it...
Feb 25, 2021 04:05 pm ET
Study Published in JAMA Finds Hospital Availability of TCAR Associated with an Improvement in Overall Outcomes for Carotid Revascularization
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced positive results from a comparative-effectiveness study have been published in JAMA Network Open. The study found...
Feb 16, 2021 04:05 pm ET
Silk Road Medical to Report Fourth Quarter and Full Year 2020 Financial Results on March 1, 2021
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the fourth quarter and full year 2020 after market close on Monday, March 1,...
Feb 05, 2021 02:55 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Silk Road Medical, Inc. - Silk
NEW YORK, Feb. 5, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Silk Road Medical, Inc.  ("Silk Road" or the "Company") (NASDAQ: SILK). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Dec 17, 2020 04:05 pm ET
Silk Road Medical to Present at the 39th Annual J.P. Morgan Healthcare Conference
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming 39th Annual J.P. Morgan Healthcare Conference. Silk Road...
Dec 03, 2020 04:05 pm ET
Silk Road Medical Announces Changes to Board of Directors
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the appointment of Kevin Ballinger to the company’s Board of Directors. Simultaneously, the company also announced...
Nov 10, 2020 04:05 pm ET
Silk Road Medical Reports Third Quarter 2020 Financial Results
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended September 30, 2020. “We had a strong third quarter in which our...
Nov 04, 2020 04:05 pm ET
Silk Road Medical to Present at the Stifel 2020 Virtual Healthcare Conference
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming Stifel 2020 Virtual Healthcare Conference. Silk Road Medical’s...
Oct 20, 2020 04:05 pm ET
Silk Road Medical to Report Third Quarter 2020 Financial Results on November 10, 2020
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the third quarter 2020 after market close on Tuesday, November 10, 2020....
Oct 01, 2020 04:05 pm ET
Silk Road Medical Names Rick Anderson to Board of Directors
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that medical device industry veteran Rick Anderson has joined its board of directors. Anderson brings over 30...
Sep 21, 2020 04:05 pm ET
Silk Road Medical Strengthens Leadership Team
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that it is strengthening its leadership team with two appointments. William Whealon, Ph.D. has joined the company...
Sep 21, 2020 09:00 am ET
Compelling Outcomes with TCAR vs. CEA in Patients with Carotid Artery Stenosis Published in the Annals of Surgery
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that positive results from the ongoing TransCarotid Artery Revascularization (TCAR) Surveillance Project comparing...
Sep 04, 2020 08:00 am ET
Silk Road Medical to Present at the Morgan Stanley 2020 Healthcare Conference
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming Morgan Stanley 2020 Healthcare Conference. Silk Road Medical’s...
Aug 19, 2020 04:05 pm ET
ROADSTER 2 Data Publication in Stroke Demonstrates Compelling Patient Outcomes and Strong Safety Profile with TCAR
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that ROADSTER 2 study results have been published in the latest edition of the American Heart Association’s...
Aug 05, 2020 04:05 pm ET
Silk Road Medical Reports Second Quarter 2020 Financial Results
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended June 30, 2020. “While the second quarter posed several challenges, we...
Jul 23, 2020 04:35 pm ET
Silk Road Medical to Report Second Quarter 2020 Financial Results on August 5, 2020
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the second quarter 2020 after market close on Wednesday, August 5, 2020....
Jul 09, 2020 04:05 pm ET
Silk Road Medical Promotes Andrew Davis to Newly Created Position of Chief Commercial Officer
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that Andrew Davis has been promoted to Chief Commercial Officer. In this newly created role, Mr. Davis will...
Jun 30, 2020 04:05 pm ET
Society for Vascular Surgery (SVS) Issues Guidance on Competence Recommendations for TCAR
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the In-Press release of a clinical competence statement on training and credentialing for TransCarotid Artery...
May 20, 2020 04:05 pm ET
Silk Road Medical Announces Full Exercise and Closing of Over-Allotment Option
Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact, today announced that in connection with its previously announced public offering of 6,808,154 shares of its...
May 08, 2020 04:05 pm ET
Silk Road Medical Announces Closing of Follow-on Public Offering
Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact, today announced the closing of an underwritten public offering of 6,808,154 shares of its common stock at a...
May 06, 2020 01:15 am ET
Silk Road Medical Announces Pricing of Upsized Public Offering
Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact, today announced the pricing of an underwritten public offering of 6,808,154 shares of its common stock at a...
May 05, 2020 04:22 pm ET
Silk Road Medical Announces Proposed Public Offering of Common Stock
Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact, announced today the commencement of a proposed underwritten public offering of $100 million of shares of its...
Apr 30, 2020 04:05 pm ET
Silk Road Medical Reports First Quarter 2020 Financial Results
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended March 31, 2020. “As we continue through these challenging times, we...
Apr 29, 2020 04:05 pm ET
Silk Road Medical to Present at the BofA Securities 2020 Health Care Conference
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming BofA Securities 2020 Health Care Conference. Silk Road Medical’s...
Apr 21, 2020 06:15 pm ET
Silk Road Medical to Report First Quarter 2020 Financial Results on April 30, 2020
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the first quarter 2020 after market close on Thursday, April 30, 2020. Company...
Apr 06, 2020 08:00 am ET
Silk Road Medical Provides COVID-19 Pandemic Update
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today provided a corporate update in response to the COVID-19 pandemic. Silk Road Medical is committed to working closely...
Mar 05, 2020 10:00 pm ET
Silk Road Medical Announces Uplisting to the Nasdaq Global Select Market®
Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact, announced today that effective as of market open on March 6, 2020, its common stock has been approved for...
Feb 26, 2020 04:05 pm ET
Silk Road Medical Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Full Year 2020 Outlook
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months and full year ended December 31, 2019. Recent Highlights Revenue of $18.6...
Feb 13, 2020 04:05 pm ET
Silk Road Medical to Report Fourth Quarter and Full Year 2019 Financial Results on February 26, 2020
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the fourth quarter and full year 2019 after market close on Wednesday,...
Dec 19, 2019 04:05 pm ET
Silk Road Medical to Present at the 38th Annual J.P. Morgan Healthcare Conference
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming 38th Annual J.P. Morgan Healthcare Conference in San Francisco,...
Dec 17, 2019 05:01 pm ET
Results Demonstrating Favorable Outcomes with TCAR vs. TF-CAS in Patients with Carotid Artery Stenosis Published in the Journal of the American Medical Association (JAMA)
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that positive results from the ongoing TransCarotid Artery Revascularization (TCAR) Surveillance Project comparing...
Nov 22, 2019 12:24 pm ET
Favorable Outcomes with TCAR vs. Carotid Endarterectomy in Patients with Carotid Artery Disease
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the presentation of real-world data for the treatment of patients with carotid artery disease at risk for stroke at...
Nov 05, 2019 04:05 pm ET
Silk Road Medical to Present at the Stifel 2019 Healthcare Conference
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming Stifel 2019 Healthcare Conference in New York, NY. Silk Road...
Oct 29, 2019 04:03 pm ET
Silk Road Medical Reports Third Quarter 2019 Financial Results
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended September 30, 2019. “Our third quarter results reflect strong...
Oct 14, 2019 04:05 pm ET
Silk Road Medical to Report Third Quarter 2019 Financial Results on October 29, 2019
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the third quarter 2019 after market close on Tuesday, October 29, 2019....
Aug 13, 2019 04:05 pm ET
Silk Road Medical Announces Closing of Follow-on Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact, today announced the closing of a public offering of 4,200,000 shares of its common stock sold by selling...
Aug 08, 2019 06:33 pm ET
Silk Road Medical Announces Pricing of Upsized Public Offering
Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact, today announced the pricing of an upsized secondary public offering of 4,200,000 shares of its common stock...
Aug 06, 2019 04:29 pm ET
Silk Road Medical Announces Proposed Public Offering of Common Stock
Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact, announced today the commencement of a proposed underwritten public offering of 3,500,000 shares of its common...
Jul 29, 2019 04:03 pm ET
Silk Road Medical Reports Second Quarter 2019 Financial Results and Raises 2019 Outlook
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended June 30, 2019. Recent Highlights Revenue of $14.9 million for...
Jul 22, 2019 04:03 pm ET
Silk Road Medical to Report Second Quarter 2019 Financial Results on July 29, 2019
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the second quarter 2019 after market close on Monday, July 29, 2019. Company...
Jun 15, 2019 01:53 pm ET
ROADSTER-2 Demonstrates Compelling Patient Outcomes with Strong Safety Profile
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced positive final results for the company’s ROADSTER-2 post-marketing study evaluating real world use of the ENROUTE®...
Jun 13, 2019 08:46 am ET
TCAR Achieves Favorable Outcomes vs. Carotid Endarterectomy in Patients with Carotid Artery Disease
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the presentation of real-world data for the treatment of patients with carotid artery disease at risk for stroke at...
Jun 11, 2019 04:05 pm ET
Silk Road Medical to Present at the BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming BMO Capital Markets 2019 Prescriptions for Success Healthcare...
Jun 04, 2019 04:05 pm ET
Silk Road Medical Announces Key TCAR Presentations at the Society for Vascular Surgery 2019 Vascular Annual Meeting
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced key data from the SVS TCAR Surveillance Project and ROADSTER-2 study will be presented at the upcoming Society for...
May 08, 2019 04:03 pm ET
Silk Road Medical Reports First Quarter 2019 Financial Results
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended March 31, 2019. Recent Highlights Recorded revenues of $12.8...
May 01, 2019 04:05 pm ET
Silk Road Medical to Present at the Bank of America Merrill Lynch 2019 Health Care Conference
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming Bank of America Merrill Lynch 2019 Health Care Conference in Las...
Apr 29, 2019 04:05 pm ET
Silk Road Medical to Report First Quarter 2019 Financial Results on May 8, 2019
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the first quarter 2019 after market close on Wednesday, May 8, 2019. Company...
Apr 08, 2019 04:05 pm ET
Silk Road Medical Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact, today announced the closing of its initial public offering of 6,000,000 shares of common stock, and the...
Apr 03, 2019 07:06 pm ET
Silk Road Medical Announces Pricing of Initial Public Offering
Silk Road Medical, Inc. (Nasdaq:SILK) (“Silk Road Medical”) today announced the pricing of its initial public offering of 6,000,000 shares of common stock at a public offering price of $20.00 per share. All of the shares of common stock are being...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.